Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial.
Frederik M ZimmermannVictoria Y DingNico H J PijlsZsolt PiróthAlbert H M van StratenLaszlo SzekelyGiedrius DavidaviciusGintaras KalinauskasSamer MansourRajesh K KharbandaNikolaos Östlund-PapadogeorgosAdel AminianKeith G OldroydNawwar Al-AttarNikola JagicJan-Henk E DambrinkPetr KalaOskar AngerasPhilip MacCarthyOlaf WendlerFilip P CasselmanNils WittKreton MavromatisSteven E S MinerJaydeep SarmaThomas EngstrømEvald Høj ChristiansenPim A L ToninoMichael J ReardonHisao OtsukiYuhei KobayashiMark A HlatkyKenneth W MahaffeyManisha DesaiYiping Joseph WooAlan C YeungBernard de BruyneWilliam F Fearonnull nullPublished in: Circulation (2023)
gov; Unique identifier: NCT02100722.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- coronary artery bypass
- minimally invasive
- cardiovascular events
- coronary artery bypass grafting
- study protocol
- phase iii
- clinical trial
- phase ii
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- antiplatelet therapy
- surgical site infection
- aortic stenosis
- randomized controlled trial
- open label
- acute coronary syndrome
- heart failure
- coronary artery
- atrial fibrillation
- transcatheter aortic valve replacement
- left ventricular